Matches in Wikidata for { <http://www.wikidata.org/entity/Q81530835> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q81530835 description "artículu científicu espublizáu en marzu de 2005" @default.
- Q81530835 description "scientific article published on 01 March 2005" @default.
- Q81530835 description "wetenschappelijk artikel" @default.
- Q81530835 description "наукова стаття, опублікована в березні 2005" @default.
- Q81530835 name "Synthesis and pharmacological evaluation of huprine-tacrine heterodimers: subnanomolar dual binding site acetylcholinesterase inhibitors" @default.
- Q81530835 name "Synthesis and pharmacological evaluation of huprine-tacrine heterodimers: subnanomolar dual binding site acetylcholinesterase inhibitors" @default.
- Q81530835 type Item @default.
- Q81530835 label "Synthesis and pharmacological evaluation of huprine-tacrine heterodimers: subnanomolar dual binding site acetylcholinesterase inhibitors" @default.
- Q81530835 label "Synthesis and pharmacological evaluation of huprine-tacrine heterodimers: subnanomolar dual binding site acetylcholinesterase inhibitors" @default.
- Q81530835 prefLabel "Synthesis and pharmacological evaluation of huprine-tacrine heterodimers: subnanomolar dual binding site acetylcholinesterase inhibitors" @default.
- Q81530835 prefLabel "Synthesis and pharmacological evaluation of huprine-tacrine heterodimers: subnanomolar dual binding site acetylcholinesterase inhibitors" @default.
- Q81530835 P1433 Q81530835-496FDCB1-8D42-41B5-8448-F2F256BC67CE @default.
- Q81530835 P1476 Q81530835-C959603E-7A85-447D-B1A6-07B4189F1BB3 @default.
- Q81530835 P2093 Q81530835-18BE53C1-4170-4239-A20D-487F36247143 @default.
- Q81530835 P2093 Q81530835-2DC71CD7-A79F-444A-BE95-0462684D6F67 @default.
- Q81530835 P2093 Q81530835-9D24210D-F408-407C-A048-7467D5B71049 @default.
- Q81530835 P2093 Q81530835-A20C47E8-8F6A-4792-984B-4F8BE440D9DB @default.
- Q81530835 P304 Q81530835-DF455B1E-FC13-4D2A-A4A0-2C3CBEC65802 @default.
- Q81530835 P31 Q81530835-436311F7-807A-4611-A4FC-4CDF9E642CEB @default.
- Q81530835 P356 Q81530835-229858B3-5ABA-4AA8-80B5-B26F7E19C903 @default.
- Q81530835 P433 Q81530835-258DFA2D-523D-47F0-AFDC-93249E757A26 @default.
- Q81530835 P478 Q81530835-0EFCE427-0103-4E38-989B-AB7FC5BBB65D @default.
- Q81530835 P50 Q81530835-8D15C56D-F4BD-472C-9A67-1A492A158442 @default.
- Q81530835 P50 Q81530835-B031793B-C418-4CF6-91CA-875C5D4028BB @default.
- Q81530835 P577 Q81530835-30F05534-8254-4FEB-86BB-1DE6C4F3E2EA @default.
- Q81530835 P698 Q81530835-3884D32E-882C-4837-B3D1-F9620704D38B @default.
- Q81530835 P356 JM0496741 @default.
- Q81530835 P698 15771413 @default.
- Q81530835 P1433 Q900316 @default.
- Q81530835 P1476 "Synthesis and pharmacological evaluation of huprine-tacrine heterodimers: subnanomolar dual binding site acetylcholinesterase inhibitors" @default.
- Q81530835 P2093 "Albert Badia" @default.
- Q81530835 P2093 "Julien Petrignet" @default.
- Q81530835 P2093 "M Victoria Clos" @default.
- Q81530835 P2093 "Xavier Formosa" @default.
- Q81530835 P304 "1701-1704" @default.
- Q81530835 P31 Q13442814 @default.
- Q81530835 P356 "10.1021/JM0496741" @default.
- Q81530835 P433 "6" @default.
- Q81530835 P478 "48" @default.
- Q81530835 P50 Q42944873 @default.
- Q81530835 P50 Q42944879 @default.
- Q81530835 P577 "2005-03-01T00:00:00Z" @default.
- Q81530835 P698 "15771413" @default.